Recruiting Pulmonary Embolism Studies in Vienna
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to t...
About Pulmonary Embolism Clinical Trials in Vienna
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Vienna, VIENNA. These studies are seeking a combined 317 participants. Research is being sponsored by Ipsen, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Vienna — FAQ
Are there pulmonary embolism clinical trials in Vienna?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Vienna, VIENNA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Vienna?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vienna research site will contact you about next steps.
Are clinical trials in Vienna free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vienna studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Vienna are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov